Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Choosing wisely recommendations regarding the top five list of procedures to avoid in the treatment of viral hepatitis: A position statement from the Brazilian Society of Hepatology endorsed by the Latin American Association for the Study of the liver.
Villela-Nogueira CA, Ferraz MLG, Pessoa MG, Souto FJD, Nabuco LC, Coelho HSM, Ridruejo E, Silva M, Bittencourt PL, Brandão-Mello CE; Members of the Brazilian Society of Hepatology. Villela-Nogueira CA, et al. Among authors: pessoa mg. Ann Hepatol. 2023 Jan-Feb;28(1):100764. doi: 10.1016/j.aohep.2022.100764. Epub 2022 Sep 28. Ann Hepatol. 2023. PMID: 36182033 Free article.
[National survey about management and treatment options of hepatitis C recurrence after liver transplantation].
Bittencourt PL, Silva Rde C, Pessoa MG, Marroni CA; Colaboradores do Inquérito Nacional de Avaliação de Impacto de Recurrência da Hepatite C no Pós-Operatório do Transplante de Fígado. Bittencourt PL, et al. Among authors: pessoa mg. Arq Gastroenterol. 2007 Jan-Mar;44(1):78-84. doi: 10.1590/s0004-28032007000100017. Arq Gastroenterol. 2007. PMID: 17639189 Free article. Portuguese.
Latin American Association for the Study of the Liver recommendations on treatment of hepatitis C.
Méndez-Sánchez N, Paraná R, Cheinquer H, Alves de Mattos A, Gadano A, Silva M, Pessôa MG, Gomes-Ferraz ML, Soza A, Mendes-Correa MC, Chávez-Tapia NC, Dagher L, Padilla M, Hernandez N, Sánchez-Avila JF, Contreras F, Moraes-Coelho HS, Parise ER, Bessone F, Uribe M; Latin American Association for the Study of the Liver. Méndez-Sánchez N, et al. Among authors: pessoa mg. Ann Hepatol. 2014 Aug;13 Suppl 2:s4-66. Ann Hepatol. 2014. PMID: 25185535 Free article. Review. No abstract available.
Disease burden of chronic hepatitis C in Brazil.
Ferreira PR, Brandão-Mello CE, Estes C, Gonçales Júnior FL, Coelho HS, Razavi H, Cheinquer H, Wolff FH, Ferraz ML, Pessoa MG, Mendes-Correa MC. Ferreira PR, et al. Among authors: pessoa mg. Braz J Infect Dis. 2015 Jul-Aug;19(4):363-8. doi: 10.1016/j.bjid.2015.04.004. Epub 2015 Jun 4. Braz J Infect Dis. 2015. PMID: 26051505 Free PMC article.
Effectiveness and safety of first-generation protease inhibitors in real-world patients with hepatitis C virus genotype 1 infection in Brazil: a multicenter study.
Callefi LA, Villela-Nogueira CA, de Barros Tenore S, Carnaúba-Júnior D, Coelho HSM, Pinto PTA, Nabuco LC, Pessoa MG, Ferraz MLCG, Ferreira PRA, de Lourdes Candolo Martinelli A, Chachá SGF, de Souza Paiva Ferreira A, de Macedo Bisio AP, Brandão-Mello CE, Álvares-Da-Silva MR, Reuter T, Ivantes CAP, de Mello Perez R, Mendes-Correa MCJ. Callefi LA, et al. Among authors: pessoa mg. Clinics (Sao Paulo). 2017 Jun;72(6):378-385. doi: 10.6061/clinics/2017(06)08. Clinics (Sao Paulo). 2017. PMID: 28658438 Free PMC article. Clinical Trial.
Peginterferon still has a place in the treatment of hepatitis C caused by genotype 3 virus.
Grando AV, Ferreira PRA, Pessôa MG, Mazo DFC, Brandão-Mello CE, Reuter T, Martinelli ALC, Gonzalez MP, Nastri ACS, Campos AF, Lopes MIBF, Brito JDU, Mendes-Corrêa MC. Grando AV, et al. Among authors: pessoa mg. Rev Inst Med Trop Sao Paulo. 2017 Nov 6;59:e67. doi: 10.1590/S1678-9946201759067. Rev Inst Med Trop Sao Paulo. 2017. PMID: 29116287 Free PMC article.
Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir ± Ribavirin for HCV in Brazilian Adults with Advanced Fibrosis.
Pessoa MG, Ramalho-Madruga JV, Alves K, Nunes EP, Cheinquer H, Brandão-Mello CE, Mendes-Correa MC, Ferraz ML, Ferreira PRA, Álvares-da-Silva MR, Coelho HS, Affonso-de-Araújo ES, Furtado J, Parana R, Silva G, Lari SA, Liu L, Tripathi R, Pilot-Matias T, Cohen DE, Shulman NS, Martinelli A. Pessoa MG, et al. Ann Hepatol. 2018 Oct 16;17(6):959-968. doi: 10.5604/01.3001.0012.7196. Ann Hepatol. 2018. PMID: 30600291 Free article. Clinical Trial.
Hepatitis C disease burden and strategies for elimination by 2030 in Brazil. A mathematical modeling approach.
Benzaken AS, Girade R, Catapan E, Pereira GFM, Almeida EC, Vivaldini S, Fernandes N, Razavi H, Schmelzer J, Ferraz ML, Ferreira PRA, Pessoa MG, Martinelli A, Souto FJD, Walsh N, Mendes-Correa MC. Benzaken AS, et al. Among authors: pessoa mg. Braz J Infect Dis. 2019 May-Jun;23(3):182-190. doi: 10.1016/j.bjid.2019.04.010. Epub 2019 May 27. Braz J Infect Dis. 2019. PMID: 31145876 Free PMC article.
Efficacy and safety of glecaprevir/pibrentasvir in treatment-naïve adults with chronic hepatitis C virus genotypes 1-6 in Brazil.
Peribañez-Gonzalez M, Cheinquer H, Rodrigues L, Lima MP, Álvares-da-Silva MR, Madruga J, Parise ER, Pessoa MG, Furtado J, Villanova M, Ferreira A, Mazzoleni F, Nascimento E, Silva GF, Fredrick L, Krishnan P, Burroughs M, Reuter T. Peribañez-Gonzalez M, et al. Among authors: pessoa mg. Ann Hepatol. 2021 Jan-Feb;20:100257. doi: 10.1016/j.aohep.2020.09.002. Epub 2020 Sep 17. Ann Hepatol. 2021. PMID: 32949786 Free article. Clinical Trial.
83 results